Company intelligence / Profile preview

RARE-X

Aliso Viejo, California, United States

Ownership: Private
Development stage: Other

Overview

RARE-X is a rare disease technology nonprofit/program of Global Genes that operates a federated, patient-driven data collection and sharing platform to support diagnosis, natural history understanding, and therapeutic research across many rare diseases; it does not develop its own therapeutics or run interventional clinical trials.[1][2][3][4][5][7]

Therapeutic areas: NeurologyRare Diseases
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Critical Path Institute (C-Path)[4]Broad Institute of MIT and Harvard (technology collaboration)[3]Sage Bionetworks/DREAM Challenge (Xcelerate RARE data challenge)[5]Roche (Xcelerate RARE sponsor/partner)[5]Alliance for Artificial Intelligence in Healthcare[5]NetraMark[5]RTW Charitable Foundation (Xcelerate RARE sponsor)[5]

Beyond the preview

Go deeper on RARE-X.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RARE-X.

Explore the full profile